![Man ultramarathon runner in the mountains he trains at sunset](https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/0B4B1380-42EB-4FD5-9D7E2DBC603E79F8/webimage-C4875379-1478-416F-B03DF68FE3D8DBB5.png)
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
CORRECTION article
Front. Microbiol. , 01 December 2023
Sec. Infectious Agents and Disease
Volume 14 - 2023 | https://doi.org/10.3389/fmicb.2023.1324539
This article is a correction to:
Unraveling the interplay between norovirus infection, gut microbiota, and novel antiviral approaches: a comprehensive review
A corrigendum on
Unraveling the interplay between norovirus infection, gut microbiota, and novel antiviral approaches: a comprehensive review
by Bai, G.-H., Tsai, M.-C., Lin, S.-C., Hsu, Y.-H., and Chen, S.-Y. (2023). Front. Microbiol. 14:1212582. doi: 10.3389/fmicb.2023.1212582
In the published article, there was an error in the Funding statement. The statement previously read “The study was supported by grants from MOST 108-2314- B-038−097 and MOST 111-2622-E-038-001, Taiwan.” The correct Funding statement appears below.
The study was supported by grants from NSTC 112-2622-E-038-004, Taiwan.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: norovirus, microbiota, probiotics, norovirus vaccine, human intestinal enteroid
Citation: Bai G-H, Tsai M-C, Lin S-C, Hsu Y-H and Chen S-Y (2023) Corrigendum: Unraveling the interplay between norovirus infection, gut microbiota, and novel antiviral approaches: a comprehensive review. Front. Microbiol. 14:1324539. doi: 10.3389/fmicb.2023.1324539
Received: 19 October 2023; Accepted: 15 November 2023;
Published: 01 December 2023.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2023 Bai, Tsai, Lin, Hsu and Chen. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Shih-Yen Chen, MTgxNTlAcy50bXUuZWR1LnR3
†These authors have contributed equally to this work
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.